Cyclophosphamide Drug

Methotrexate, a commonly used drug for rheumatoid arthritis (RA), will not raise patients' risk of developing blood cancers, a new study has found. But cyclophosphamide, a less common medication, doubles a patient's risk of developing lymphoma. Cyclophosphamide is sometimes used to treat very severe RA, particularly cases where the disease has progressed to the point of damaging organs. Experts say these findings highlight the need for continued research into safer drugs to treat very severe for... Read more »